GlaxoSmithKline plc is seeking a partner to transform a third of its R&D site in Stevenage, UK, in a move that would create one of Europe’s largest life science campuses and raise £400m for the drugs major.
As part of proposals set out on 16 July, GSK is looking to sell 33 acres of land, with an...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?